(Q34508771)

English

Renal and systemic effects of continued treatment with renin inhibitor remikiren in hypertensive patients with normal and impaired renal function

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Renal and systemic effects of continued treatment with renin inhibitor remikiren in hypertensive patients with normal and impaired renal function (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

van Paassen P

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

de Zeeuw D

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Navis G

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

de Jong PE

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

0 references

publication date

1 May 2000

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Nephrology Dialysis Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

15

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

637-643

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

Renal circulation and blockade of the renin-angiotensin system. Is angiotensin-converting enzyme inhibition the last word?

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

Distribution of remikiren, a potent orally active inhibitor of human renin, in laboratory animals

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

Renal vascular responses to renin inhibition with zankiren in men*

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

Immediate blood pressure effects of the renin inhibitor enalkiren and the angiotensin-converting enzyme inhibitor enalaprilat

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

Comparison of blood pressure and angiotensin responses to the renin inhibitor Ro 42-5892 and the angiotensin converting enzyme inhibitor enalapril in essential hypertension

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

Plasma angiotensins, renin, and blood pressure during acute renin inhibition by CGP 38 560A in hypertensive patients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

Effects of an orally active renin inhibitor, Ro 42-5892, in patients with essential hypertension.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

Renal and systemic effects of the renin inhibitor remikiren in patients with essential hypertension

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

Renal and endocrine responses to a renin inhibitor, enalkiren, in normal humans

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

Responses to converting enzyme and renin inhibition. Role of angiotensin II in humans

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

Comparison of a new renin inhibitor and enalaprilat in renal hypertensive dogs

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

Effects of blocking the angiotensin II receptor, converting enzyme, and renin activity on the renal hemodynamics of normotensive guinea pigs.

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

Assays to measure nanomolar levels of the renin inhibitor CGP 38 560 in plasma

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

Comparative effects of three different potent renin inhibitors in primates

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

Pharmacokinetics of remikiren, a potent orally active inhibitor of human renin, in rat, dog and primates

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

Diuretic effects of angiotensin-converting enzyme inhibition: comparison of low and liberal sodium diet in hypertensive patients

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

A short-term antihypertensive treatment-induced fall in glomerular filtration rate predicts long-term stability of renal function

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

Long-term benefits of the antiproteinuric effect of angiotensin-converting enzyme inhibition in nondiabetic renal disease

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

Pathways for angiotensin II generation in intact human tissue: evidence from comparative pharmacological interruption of the renin system

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

Dissociation between the course of the hemodynamic and antiproteinuric effects of angiotensin I converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2F15.5.637

21 January 2018

Identifiers

10.1093/NDT/15.5.637

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34508771&oldid=1960963708"